Adalimumab in anti-synthetase syndrome

Joint Bone Spine

Volumn 80, Issue 4, 2013, Pages 432-

  da Silva, Thiago Costa Pamplona ^a   Zon Pretti, Flavia ^a   Shinjo, Samuel Katsuyuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; LEFLUNOMIDE;

ADULT; ANTISYNTHETASE SYNDROME; CASE REPORT; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAPHY; FEMALE; FEVER; FOLLOW UP; HUMAN; LETTER; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; POLYARTHRITIS; RAYNAUD PHENOMENON;

EID: 84880325101     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.10.012     Document Type: Letter

References (9)

1. Dastmalchi M., Grundtman C., Alexanderson H., et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis 2008, 67:1670-1677.
2. Labioche L., Liozon E., Weschler B., et al. Refractory polymyositis responding in infliximab: extended follow-up. Rheumatol 2004, 43:531-532.
3. Iannone F., Scioscia C., Falappone P.C.F., et al. Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol 2006, 33:1802-1804.
4. Sprott H., Glatzel M., Mitchel B.A. Treatment of myositis with etanercept/Enbrel, a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1. Rheumatol 2004, 43:524-526.
5. Nagashima T., Minota S. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy. J Rheumatol 2011, 38:574.
6. Klein R., Rosenbach M., Kim E.J., et al. Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol 2010, 146:780-784.
7. Brunasso A.M., Scocco G.L., Massone C. Dermatomyositis during adalimumab therapy for rheumatoid arthritis. J Rheumatol 2010, 37:1549-1550.
8. Souza F.H.C., Barros T.B.M., Levy-Neto M., et al. Adalimumab induced-inflammatory myopathy in rheumatoid arthritis. Acta Reumatol Port 2012, 37:180-183.
9. Vordenbäumen S., Neuen-Jacob E., Richter J., et al. Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFalpha and rituximab. Clin Rheumatol 2010, 29:555-558.